Home » ASTELLAS TERMINATES LICENSING AGREEMENT WITH SERVIER
ASTELLAS TERMINATES LICENSING AGREEMENT WITH SERVIER
Astellas Pharma Inc. (4503.TO) said Tuesday it has terminated its licensing agreement on an osteoporosis drug with Laboratoires Servier SA (LSV.YY), a privately owned French drugmaker.
Therapeutics Daily
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May